| Serial Number | 98371742 |
| Word Mark | QURE |
| Filing Date | Tuesday, January 23, 2024 |
| Status | 653 - SUSPENSION LETTER - MAILED |
| Status Date | Thursday, December 18, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Viral systems, gene therapy systems, and nucleic acid delivery systems, all comprised of biological preparations in the nature of viruses for use in cell cultures for non-medical, scientific research purposes; viral vectors, non-viral vectors, gene therapy vectors, nucleic acid delivery vectors, and cells transformed by viral vectors, non-viral vectors, gene therapy vectors and nucleic acid delivery vectors all comprised of biological preparations in the nature of viruses for use in cell cultures for non-medical, scientific research purposes |
| Goods and Services | Medical and scientific research, product development and consultancy in the fields of biotechnology, biology, biopharmaceutical research and development, medical science, chemistry and biochemistry; Providing medical and scientific research information and advice in the fields of biotechnology, biology, biopharmaceutical research and development, medical science, chemistry and biochemistry |
| Goods and Services | Medical treatment of metabolic disorders, ocular disorders, diseases of the nervous system, blood disorders, liver disorders, muscular disorders, muscular skeletal disorders, cancers, infectious diseases, inflammatory and auto-immune diseases, vascular disorders, inherited disorders, genetic disorders and single gene disorders using gene and nucleic acid delivery, gene and nucleic acid transfer, gene and nucleic acid regulation and gene and nucleic acid modulation; Providing medical information and advice in the field of medical treatment of metabolic disorders, ocular disorders, diseases of the nervous system, blood disorders, liver disorders, muscular disorders, muscular skeletal disorders, cancers, infectious diseases, inflammatory and auto-immune diseases, vascular disorders, inherited disorders, genetic disorders and single gene disorders using gene and nucleic acid delivery, gene and nucleic acid transfer, gene and nucleic acid regulation and gene and nucleic acid modulation |
| Goods and Services | Viral systems, gene therapy systems, nucleic acid delivery systems, all comprised of biological preparations in the nature of viruses for medical purposes; viral vectors, gene therapy vectors, nucleic acid delivery vectors, all comprised of biological preparations in the nature of viruses for medical purposes; pharmaceutical products for the treatment of diseases; biological preparations for use in medical purposes, namely, in medical and clinical gene therapy, nucleic acid-based therapy; clinical medical reagents for use in nucleic acid-based therapy, gene therapy, gene diagnosis and gene testing; pharmaceutical preparations being prophylaxis products for use in nucleic acid-based therapy and gene therapy |
| Translation of Words in Mark | The wording QURE has no meaning in a foreign language. |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, January 23, 2024 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, January 23, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, January 23, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, January 23, 2024 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | uniQure IP B.V. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Amsterdam 1105BP NL |
| Event Date | Event Description |
| Tuesday, January 23, 2024 | NEW APPLICATION ENTERED |
| Friday, May 24, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, August 19, 2024 | ASSIGNED TO EXAMINER |
| Tuesday, August 27, 2024 | NON-FINAL ACTION WRITTEN |
| Tuesday, August 27, 2024 | NON-FINAL ACTION E-MAILED |
| Tuesday, August 27, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, October 15, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, October 15, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, October 16, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, November 5, 2024 | SUSPENSION LETTER WRITTEN |
| Tuesday, November 5, 2024 | LETTER OF SUSPENSION E-MAILED |
| Tuesday, November 5, 2024 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Tuesday, April 1, 2025 | ASSIGNED TO EXAMINER |
| Thursday, May 8, 2025 | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION |
| Tuesday, September 9, 2025 | ASSIGNED TO EXAMINER |
| Tuesday, September 9, 2025 | SUSPENSION INQUIRY WRITTEN |
| Tuesday, September 9, 2025 | INQUIRY TO SUSPENSION E-MAILED |
| Tuesday, September 9, 2025 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED |
| Tuesday, December 2, 2025 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Monday, December 15, 2025 | ASSIGNED TO LIE |
| Monday, December 15, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, December 15, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, December 18, 2025 | SUSPENSION LETTER WRITTEN |
| Thursday, December 18, 2025 | LETTER OF SUSPENSION E-MAILED |
| Thursday, December 18, 2025 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |